The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 21, 2023

Filed:

Mar. 12, 2013
Applicant:

Amgen Inc., Thousand Oaks, CA (US);

Inventors:

Yatin R. Gokarn, Foster City, CA (US);

Eva Kras, Redmond, WA (US);

Richard Louis Remmele, Jr., Mountain View, CA (US);

David Brems, Newbury Park, CA (US);

Susan Irene Hershenson, Newbury Park, CA (US);

Assignee:

Amgen Inc., Thousand Oaks, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 51/00 (2006.01); A61K 39/395 (2006.01); A61K 9/08 (2006.01); C07K 16/00 (2006.01); A61K 47/02 (2006.01); C07K 16/24 (2006.01); C07K 16/28 (2006.01); A61K 47/10 (2017.01); A61K 47/26 (2006.01);
U.S. Cl.
CPC ...
A61K 39/3955 (2013.01); A61K 9/08 (2013.01); A61K 39/39591 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/26 (2013.01); C07K 16/00 (2013.01); C07K 16/241 (2013.01); C07K 16/2803 (2013.01); C07K 16/2827 (2013.01); C07K 16/2851 (2013.01); C07K 16/2866 (2013.01); C07K 16/2875 (2013.01); C07K 2317/21 (2013.01); C07K 2317/565 (2013.01); C07K 2317/94 (2013.01);
Abstract

The invention herein described, provides, among other things, self-buffering protein formulations. Particularly, the invention provides self-buffering pharmaceutical protein formulations that are suitable for veterinary and human medical use. The self-buffering protein formulations are substantially free of other buffering agents, stably maintain pH for the extended time periods involved in the distribution and storage of pharmaceutical proteins for veterinary and human medical use. The invention further provides methods for designing, making, and using the formulation. In addition to other advantages, the formulations avoid the disadvantages associated with the buffering agents conventionally used in current formulations of proteins for pharmaceutical use. The invention in these and other respects can be productively applied to a wide variety of proteins and is particularly useful for making and using self-buffering formulations of pharmaceutical proteins for veterinary and medical use, especially, in particular, for the treatment of diseases in human subjects.


Find Patent Forward Citations

Loading…